Sitafloxacin Fumarate

富马酸西他沙星

Report date: 2026/03/04 20:01:44

Base Information

Drug NameSitafloxacin Fumarate
Drug Alias Name西他沙星富马酸盐
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsCommunity-acquired bacterial pneumoniaPyelonephritisUrinary Tract Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNanjing Yoko Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Yoko Biomedical Co LtdNanjing Yoko Pharmaceutical Co LtdNanjing Yoko Biomedical Research Co Ltd
Inactive CompaniesN/A
Active IndicationsCommunity-acquired bacterial pneumoniaPyelonephritisUrinary Tract Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG